People & Positions

And this week, I'm going to give you a taste of some of the very cool stuff five of them are working on, which includes lifesaving innovations and groundbreaking age reversal" tech. Preventing maternal deaths Let's start with Paschal Kija, a 28-year-old who has developed a device to treat postpartum hemorrhage—a dangerous birth complication that contributes to around 29% of maternal deaths in his home country, Tanzania. Inspired by kirigami—the traditional Japanese art of cutting paper to form three-dimensional shapes—she's created a sheet of electrodes with a honeycombed structure shaped like a spiral basket. Reversing the aging process to treat eye disease The buzziest tech in longevity right now centers on reprogramming—attempts to rewind the age of cells by resetting them to a more embryonic-like state."

Queen's University Belfast, as part of a seven-institution all-island ageing research network, has received funding to train future health professional leaders across the island of Ireland. The Irish Clinical Academic Training-Accelerating Health Research to Support Ageing Demographics (ICAT-AHEAD) Programme, received a funding boost from Wellcome. The programme will be led by Professor Bernadette McGuinness from the School of Medicine, Dentistry and Biomedical Sciences at Queen's University Belfast, working in partnership with RCSI University of Medicine and Health Sciences, Trinity College Dublin, Ulster University, University College Cork, the University of Galway and University College Dublin.

Marc Stegger fra Statens Serum Institut (SSI) blev fredag tildelt årets forskningslegat fra Professor dr.med. Fritz Kauffmanns Forskningsfond på baggrund af sin stærke akademiske profil og mangeårige forskningsindsats inden for mikrobielle patogener og antibiotikaresistens. Marc Steggers forskning har blandt andet bidraget til udviklingen af genombaserede metoder og en national infrastruktur for mikrobielle sekvensdata, som kan understøtte diagnostik, overvågning og forskning. Forskningslegatet gives til støtte for Marc Steggers fortsatte forskning og skal blandt andet bidrage til, at han kan videreudvikle sine forskningsområder og udbygge de samarbejder, der kendetegner hans arbejde. Det betyder meget for mig, at fonden ønsker at støtte den forskning, jeg har arbejdet med gennem mange år, og som jeg håber kan være med til at gøre en forskel i vores forståelse af infektionssygdomme og mulige behandlinger, siger Marc Stegger."